Cargando…

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome

PRIMARY STUDY OBJECTIVE: Determine the frequency of abnormal fecal biomarker test results in patients with 13 irritable bowel syndrome (IBS)–related ICD-9 (International Statistical Classification of Diseases and Related Health Problems) codes. STUDY DESIGN: Quantitative review of de-identified reco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goepp, Julius, Fowler, Elizabeth, McBride, Teresa, Landis, Darryl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Advances in Health and Medicine 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030610/ https://www.ncbi.nlm.nih.gov/pubmed/24891989 http://dx.doi.org/10.7453/gahmj.2013.099

Ejemplares similares

Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study
por: Parsons, Kelly, et al.
Publicado: (2014)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
por: Ahmed, Iftikhar, et al.
Publicado: (2013)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Serum biomarkers for irritable bowel syndrome
por: CHIRA, ALEXANDRA, et al.
Publicado: (2015)

Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis
por: Ganji, Leila, et al.
Publicado: (2016)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

The Frequency of Primary Sjogren’s Syndrome and Fibromyalgia in Irritable Bowel Syndrome
por: Erbasan, Funda, et al.
Publicado: (2017)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME
por: Pujo, J, et al.
Publicado: (2023)

Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
por: Plavšić, Ivana, et al.
Publicado: (2015)

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis
por: Zhou, Xing-lu, et al.
Publicado: (2014)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome
por: Ozdil, Kamil, et al.
Publicado: (2011)

Frequency and severity of irritable bowel syndrome in cigarette smokers, Turkey 2019
por: Başpınar, Melike Mercan, et al.
Publicado: (2022)

Prevalence of Irritable Bowel Syndrome and Frequency of Symptoms in the General Population of Pakistan
por: Bachani, Parkash, et al.
Publicado: (2021)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome
por: Shankar, Vijay, et al.
Publicado: (2015)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
por: Acosta, Andrés, et al.
Publicado: (2016)

Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome
por: Goll, Rasmus, et al.
Publicado: (2020)

Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome
por: Ansari, Mina Hojat, et al.
Publicado: (2020)

Prokaryotic and Eukaryotic Fecal Microbiota in Irritable Bowel Syndrome Patients and Healthy Individuals Colonized With Blastocystis
por: Nourrisson, Céline, et al.
Publicado: (2021)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rva6gc6ou3f1eddmibafns94pg